Bioequivalence and Bioavailability Forum • BE of racemic drugs (EMA’s practice)

BE of racemic drugs (EMA’s practice) [Regulatives / Guidelines]

posted by scorp2011 – India, 2012-01-16 13:08 (3483 d 06:51 ago) – Posting: # 7944
Views: 5,404

Dear HS,

Thanks for the details. Will update the details regarding outcome of the regulatory response.

Regards
Sonu

Complete thread:

Bioequivalence of racemic drugs using non-steriospecific bio scorp2011 2012-01-12 13:21 [Regulatives / Guidelines]
- BE of racemic drugs (EMA vs. FDA) Helmut 2012-01-12 19:21
  - BE of racemic drugs (EMA vs. FDA) scorp2011 2012-01-13 06:11
    - BE of racemic drugs (EMA’s practice) Helmut 2012-01-13 16:02
      - BE of racemic drugs (EMA’s practice)scorp2011 2012-01-16 13:08
        
        BE of racemic drugs (EMA’s practice) valivetiananth 2019-12-30 13:45
        
        BE of racemic drugs (EMA’s practice) Helmut 2019-12-30 14:35

Admin contact
21,594 posts in 4,515 threads, 1,532 registered users;
online 8 (0 registered, 8 guests [including 2 identified bots]).
Forum time: Friday 20:59 CEST (Europe/Vienna)

It is a capital mistake to theorise before one has data. Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz